Literature DB >> 16595451

Relevance of in vitro and in vivo models for intervertebral disc degeneration.

Howard S An1, Koichi Masuda.   

Abstract

Models available for the study of intervertebral disc degeneration are designed to answer many important questions. In vitro biologic models employ a variety of cell, tissue, or organ culture techniques with culture conditions that partially mimic the cellular environment of the degenerated human intervertebral disc. In vitro biomechanical models include intervertebral disc or motion-segment loading experiments as well as finite element modeling techniques. The literature describes numerous in vivo animal models for use in the study of intervertebral disc degeneration, each of which has its own advantages and disadvantages. Human-subject studies have included the use of magnetic resonance imaging and other techniques to assess diffusion into the intervertebral disc, to measure intradiscal pressure, to conduct kinematic or stiffness studies of lumbar motion segments, and to evaluate muscular forces on the spine. Although all of these studies are helpful in answering specific questions, their relevance in assessing disc degeneration in patients with symptoms of discogenic pain must be carefully considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595451     DOI: 10.2106/JBJS.E.01272

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  20 in total

1.  Structured coculture of stem cells and disc cells prevent disc degeneration in a rat model.

Authors:  Aliza A Allon; Nicolas Aurouer; Bryan B Yoo; Ellen C Liebenberg; Zorica Buser; Jeffrey C Lotz
Journal:  Spine J       Date:  2010-10-25       Impact factor: 4.166

2.  MicroRNA-146a reduces IL-1 dependent inflammatory responses in the intervertebral disc.

Authors:  Su-Xi Gu; Xin Li; John L Hamilton; Ana Chee; Ranjan Kc; Di Chen; Howard S An; Jae-Sung Kim; Chun-do Oh; Yuan-Zheng Ma; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2014-10-12       Impact factor: 3.688

3.  Localized Intervertebral Disc Injury Leads to Organ Level Changes in Structure, Cellularity, and Biosynthesis.

Authors:  James C Iatridis; A J Michalek; D Purmessur; C L Korecki
Journal:  Cell Mol Bioeng       Date:  2009-09-01       Impact factor: 2.321

Review 4.  New challenges for intervertebral disc treatment using regenerative medicine.

Authors:  Koichi Masuda; Jeffrey C Lotz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

5.  The dog as an animal model for DISH?

Authors:  H C Kranenburg; L A Westerveld; J J Verlaan; F C Oner; W J A Dhert; G Voorhout; H A W Hazewinkel; B P Meij
Journal:  Eur Spine J       Date:  2010-02-02       Impact factor: 3.134

6.  Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report.

Authors: 
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

7.  In vivo intervertebral disc remodeling: kinetics of mRNA expression in response to a single loading event.

Authors:  Jeffrey J MacLean; Peter J Roughley; Robert D Monsey; Mauro Alini; James C Iatridis
Journal:  J Orthop Res       Date:  2008-05       Impact factor: 3.494

Review 8.  Role of biomechanics in intervertebral disc degeneration and regenerative therapies: what needs repairing in the disc and what are promising biomaterials for its repair?

Authors:  James C Iatridis; Steven B Nicoll; Arthur J Michalek; Benjamin A Walter; Michelle S Gupta
Journal:  Spine J       Date:  2013-01-29       Impact factor: 4.166

9.  The cellular and molecular biology of the intervertebral disc: A clinician's primer.

Authors:  W Mark Erwin; Katherine E Hood
Journal:  J Can Chiropr Assoc       Date:  2014-09

10.  Comparison of vertebral and intervertebral disc lesions in aging humans and rhesus monkeys.

Authors:  J F Bailey; A J Fields; E Liebenberg; J A Mattison; J C Lotz; P A Kramer
Journal:  Osteoarthritis Cartilage       Date:  2014-05-10       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.